Neptune Technologies & Bioressources (NEPT) Given Media Impact Score of 0.14

Share on StockTwits

Media stories about Neptune Technologies & Bioressources (NASDAQ:NEPT) (TSE:NTB) have trended somewhat positive on Wednesday, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Neptune Technologies & Bioressources earned a news impact score of 0.14 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 44.0032480978007 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

Shares of NEPT stock traded down $0.12 during trading on Wednesday, hitting $4.32. The company had a trading volume of 363,454 shares, compared to its average volume of 1,246,030. Neptune Technologies & Bioressources has a 52 week low of $0.80 and a 52 week high of $4.48.

Neptune Technologies & Bioressources (NASDAQ:NEPT) (TSE:NTB) last posted its quarterly earnings data on Tuesday, August 14th. The biotechnology company reported ($0.04) earnings per share for the quarter. The company had revenue of $4.01 million for the quarter.

Separately, BidaskClub upgraded shares of Neptune Technologies & Bioressources from a “sell” rating to a “hold” rating in a research report on Thursday, August 30th.

About Neptune Technologies & Bioressources

Neptune Technologies & Bioressources Inc, a nutrition products company, produces and commercializes nutraceutical products and turnkey solutions primarily for omega-3 softgel capsules and liquids. It offers specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils, as well as pet supplements.

Read More: Calculate Your Return on Investment (ROI)

Insider Buying and Selling by Quarter for Neptune Technologies & Bioressources (NASDAQ:NEPT)

Receive News & Ratings for Neptune Technologies & Bioressources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioressources and related companies with's FREE daily email newsletter.

Leave a Reply